These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27816489)

  • 61. Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer.
    Moquet-Torcy G; Tolza C; Piechaczyk M; Jariel-Encontre I
    Nucleic Acids Res; 2014; 42(17):11011-24. PubMed ID: 25200076
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival.
    Iskit S; Schlicker A; Wessels L; Peeper DS
    Oncotarget; 2015 Dec; 6(41):43146-61. PubMed ID: 26646695
    [TBL] [Abstract][Full Text] [Related]  

  • 63. FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy.
    Zeng F; He J; Jin X; Liao Q; Chen Z; Peng H; Zhou Y
    Biomed Pharmacother; 2022 Jun; 150():113037. PubMed ID: 35658206
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL.
    Sayan AE; Stanford R; Vickery R; Grigorenko E; Diesch J; Kulbicki K; Edwards R; Pal R; Greaves P; Jariel-Encontre I; Piechaczyk M; Kriajevska M; Mellon JK; Dhillon AS; Tulchinsky E
    Oncogene; 2012 Mar; 31(12):1493-503. PubMed ID: 21822309
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression.
    Luo YP; Zhou H; Krueger J; Kaplan C; Liao D; Markowitz D; Liu C; Chen T; Chuang TH; Xiang R; Reisfeld RA
    Oncogene; 2010 Feb; 29(5):662-73. PubMed ID: 19966854
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PKCθ-mediated serine/threonine phosphorylations of FAK govern adhesion and protrusion dynamics within the lamellipodia of migrating breast cancer cells.
    Chadelle L; Liu J; Choesmel-Cadamuro V; Karginov AV; Froment C; Burlet-Schiltz O; Gandarillas S; Barreira Y; Segura C; Van Den Berghe L; Czaplicki G; Van Acker N; Dalenc F; Franchet C; Hahn KM; Wang X; Belguise K
    Cancer Lett; 2022 Feb; 526():112-130. PubMed ID: 34826547
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Linear Integration of ERK Activity Predominates over Persistence Detection in Fra-1 Regulation.
    Gillies TE; Pargett M; Minguet M; Davies AE; Albeck JG
    Cell Syst; 2017 Dec; 5(6):549-563.e5. PubMed ID: 29199017
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1.
    He H; Song D; Sinha I; Hessling B; Li X; Haldosen LA; Zhao C
    Oncogene; 2019 Jul; 38(28):5725-5738. PubMed ID: 31015574
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications' door.
    Talotta F; Casalino L; Verde P
    Oncogene; 2020 Jun; 39(23):4491-4506. PubMed ID: 32385348
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression profiling of genes regulated by Fra-1/AP-1 transcription factor during bleomycin-induced pulmonary fibrosis.
    Rajasekaran S; Reddy NM; Zhang W; Reddy SP
    BMC Genomics; 2013 Jun; 14():381. PubMed ID: 23758685
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Emerging Function of PKCtheta in Cancer.
    Nicolle A; Zhang Y; Belguise K
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562506
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Expression of the Fra-1 gene in the peripheral blood of children with Wilms tumor].
    Cheng YF; Wang XM; Yan M; Xiao JG
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Feb; 21(2):161-164. PubMed ID: 30782279
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue.
    Kennedy S; Clynes M; Doolan P; Mehta JP; Rani S; Crown J; O'Driscoll L
    Br J Cancer; 2008 May; 98(10):1641-5. PubMed ID: 18475297
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of Fra-2 in cancer.
    Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
    Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Fra-1/AP-1 Oncoprotein: From the "Undruggable" Transcription Factor to Therapeutic Targeting.
    Casalino L; Talotta F; Cimmino A; Verde P
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326630
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop.
    Ibrahim SAE; Abudu A; Johnson E; Aftab N; Conrad S; Fluck M
    Oncotarget; 2018 Sep; 9(76):34259-34278. PubMed ID: 30344941
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ubiquitin-Specific Protease 21 Promotes Colorectal Cancer Metastasis by Acting as a Fra-1 Deubiquitinase.
    Yun SI; Hong HK; Yeo SY; Kim SH; Cho YB; Kim KK
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947604
    [TBL] [Abstract][Full Text] [Related]  

  • 78. FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer.
    Dhillon AS; Tulchinsky E
    Oncogene; 2015 Aug; 34(34):4421-8. PubMed ID: 25381818
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Editorial.
    Fields AP
    Adv Biol Regul; 2021 May; 80():100770. PubMed ID: 33310395
    [No Abstract]   [Full Text] [Related]  

  • 80. nPKCdelta a new therapeutic marker for melanoma metastasis? (Review).
    La Porta CA
    Int J Mol Med; 2000 May; 5(5):467-71. PubMed ID: 10762648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.